Oxford Drug Design is an innovative biotechnology company discovering and developing novel therapeutics supported by advanced computational methods.
Location: United Kingdom, England, Oxford
Total raised: $14.83M
Investors 6
Date | Name | Website |
- | o2h ventur... | o2hventure... |
- | Angel CoFu... | acfinvesto... |
05.04.2022 | Syndicate ... | syndicater... |
- | Oxford Uni... | innovation... |
- | Cambridge ... | cambridgea... |
- | CARB-X | carb-x.org |
Funding Rounds 3
Date | Series | Amount | Investors |
25.05.2022 | - | $2.78M | - |
19.06.2019 | Grant | $10.12M | - |
31.05.2017 | - | $1.93M | - |
Mentions in press and media 4
Date | Title | Description | Source |
19.05.2022 | Oxford Drug Design Raises £2.2M in Bridge Funding | Oxford Drug Design Limited, an Oxford, England, UK-based biotechnology company with a proprietary co... | finsmes.co... |
19.06.2019 | Oxford Drug Design receives over £8m in grant and equity inv... | Oxford Drug Design (ODD) wins major funding awards from CARB-X, the UK Department of Health and Soci... | cambridgen... |
19.06.2019 | Oxford Drug Design receives over £8m in grant and equity inv... | Oxford Drug Design receives over £8m in grant and equity investment 19-06-2019 Oxford Drug Design ... | cambridgen... |
31.05.2017 | Oxford Drug Design Ltd - Secures £1.5m financing | Oxford Drug Design Ltd (previously known as InhibOx), the leading computer aided drug design and 3... | ipgroupplc... |